Evidence map›Paper›PMID 17676373›Full record

ArticlePediatric cardiology2008

Chronic granulomatous disease associated with atypical Kawasaki disease.

M A Yamazaki-Nakashimada, N Ramírez-Vargas, J De Rubens-Figueroa

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. X-Linked Agammaglobulinemia with Kawasaki Disease.Indian journal of pediatrics · 2022
    Article
  3. Article
  4. Review
  5. p47Journal of clinical immunology · 2018
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Kawasaki's disease: An unusual presentation.Journal of cardiovascular disease research · 2012
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M A Yamazaki-NakashimadaDepartment of Clinical Immunology, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C C.P, 04530, Col. Insurgentes Cuicuilco, Mexico City, Mexico. yzki71@yahoo.com.mx
N Ramírez-Vargas
J De Rubens-Figueroa
Instituto Nacional de Pediatria · MXUniversidad Insurgentes · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic granulomatous disease (CGD) is an infrequent inherited disorder characterized by recurrent infections and abnormal granuloma formation. Patients with CGD have an exuberant inflammatory response and an increased risk of developing autoimmunity. We present the case of a 1-year-old boy with CGD who developed several of the characteristic clinical features of Kawasaki Disease. His illness responded to intravenous immunoglobulin, aspirin, and corticosteroids.

Indexed as

ComorbidityDrug Therapy, CombinationGlucocorticoidsGranulomatous Disease, ChronicHumansImmunoglobulins, IntravenousImmunologic FactorsInfantMaleMucocutaneous Lymph Node SyndromePrednisoloneGlucocorticoidsImmunoglobulins, IntravenousImmunologic FactorsPrednisolone

Identifiers

PMID17676373
OpenAlexW2055613456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.